Guillem is responsible for identifying and evaluating investment opportunities. He represents Ysios at the board of directors of its portfolio companies.
Guillem serves on the board of VarmX.
Guillem has c.a. 10 years’ experience in Venture Capital. Prior to joining Ysios, Guillem worked at Edmond de Rothschild Group in Paris (now Andera Partners). There, he was involved in the execution of several investments in Europe and United States. These included opportunities in the domain of neurodegeneration, oncology, cardiovascular pathologies, and respiratory diseases. He previously worked at Caixa Capital Risc, where he was part of the life sciences team.
Guillem is a CFA charter holder and holds a bachelor’s degree in Biotechnology from the Universitat Autonoma de Barcelona and a bachelor’s degree in Business Administration from the Universitat Pompeu Fabra.